Glioma is the first malignant tumor of the brain, most commonly astrocytoma, and is classified as grade 1, 2, 3, 4 and glioblastoma according to the degree of malignancy. Among them, grade 4 and glioblastoma are the most malignant, and the median survival time is about 10-12 months. We have introduced “cancer cell starvation therapy” from Germany to treat glioma with high malignancy. Because glioma cells can only use glucose as a source of energy, we use a specially designed diet, Chinese medicine techniques, exercise therapy and meditation therapy to starve the tumor. Currently, it has been used in Germany and the United States for the treatment of malignant gliomas with unexpected results, and studies have confirmed that this therapy has the ability to control tumor growth and reduce tumor size better than existing chemotherapy drugs. Associate Professor Haisheng Liu, a neurosurgeon at Tsinghua University Yuquan Hospital and a master’s student at Tsinghua University, together with Sanqi Zhengkang International Medical Research Institute, is the first to start using this method for glioma treatment in China, expecting that another treatment technology with definite efficacy after surgery, radiotherapy and chemotherapy will be available soon for the benefit of glioma patients. Who is suitable for this treatment: Patients with glioma or glioblastoma of high malignancy, whose growth cannot be controlled by surgery, radiotherapy or chemotherapy, or who cannot be treated surgically, are suitable for this “cancer cell starvation therapy”. We will keep you informed of the clinical results of the cases undergoing treatment.